Dexmedetomidine for EEG sedation in children with behavioral disorders.
Francesca SfrisoClaudia Maria BonardiFrancesco ViaggiStefano SartoriClementina BoniverFrancesco MartinolliLiviana Da DaltAnna Chiara FrigoAlessandro MazzaAngela AmigoniPublished in: Acta neurologica Scandinavica (2020)
Intravenous dexmedetomidine as a single drug showed an excellent efficacy and good safety profile for EEG recording in children with behavioral disorders.